GlassScriptPhysician profile
Alexandra Kostick
NPI 1215927702
$1,039.88
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $388 · 2020: $117 · 2021: $151 · 2022: $210 · 2023: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $175.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $219.28 | 2019-2022 | |
| Kala Pharmaceuticals, INC. | $154.53 | 2019-2021 | |
| Glaukos Corporation | $84.01 | 2019-2022 | |
| Horizon Therapeutics Plc | $77.46 | 2022-2023 | Tepezza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $67.24 | 2019-2021 | |
| Rayner Intraocular Lenses Limited | $62.55 | 2022-2023 | Rayone Emv, Rayone Spheric, Rayone Aspheric |
| Thea Pharma INC. | $57.50 | 2023 | Iyuzeh |
| Sight Sciences, INC. | $57.00 | 2019-2022 | |
| Shire North American Group INC | $43.01 | 2019 | |
| Mallinckrodt Hospital Products INC. | $39.57 | 2023 | Acthar |
| Johnson & Johnson Surgical Vision, INC. | $23.53 | 2022 | |
| Dompe US, INC. | $23.43 | 2020 | |
| Eyevance Pharmaceuticals LLC | $23.35 | 2021 | |
| Abbvie INC. | $22.88 | 2022 | |
| New World Medical,INC. | $20.28 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Omeros Corporation | $18.11 | 2021 | |
| Sun Pharmaceutical Industries INC. | $16.39 | 2020 | |
| Allergan, INC. | $14.98 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Kostick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.